|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Glucose Intolerance | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetes Mellitus | |||||
| Diabetes Mellitus, Type 2 | |||||
| 3 | More general conditions related to this trial | ||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Hyperglycemia | |||||
| Metabolic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Intensive lifestyle | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| National Institute on Aging (NIA) | |||||
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |||||
| National Center on Minority Health and Health Disparities (NCMHD) | |||||
| Office of Research on Women's Health (ORWH) | |||||